Zika Virus Vaccines
The Live-Attenuated vaccine is developed to the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos. The understanding of flavivirus particle structure, definition of E dimers as the key antigenic target, and deep understanding of neutralization mechanisms help to develop the vaccine.
- Zika Virus Vaccine Development
- Zika Virus Vaccines Recent Research
- Zika Virus Vaccines Clinical Trials
- Zika Virus Vaccine in Pregnant Women
- Purified Inactivated Vaccine
- DNA Vaccine
- Live Attenuated Vaccine
- DNA and mRNA Vaccine
Related Conference of Zika Virus Vaccines
March 10-11, 2021
4th International Conference on Vaccines, Immunization and Clinical Trials
Amsterdam, Netherlands
Zika Virus Vaccines Conference Speakers
Recommended Sessions
- Allergy & Asthma Vaccines
- Antibodies Research
- Aquaculture Vaccines
- Chicken pox Vaccines
- Clinical Immunology & Immunopathology
- Flu Vaccines
- HIV Vaccines
- HPV Vaccines
- Immune System Disorders
- Immunization Challenges
- Immunology
- Infectious and Non infectious diseases Vaccines
- Onco Immunology
- Paediatric Immunology
- Paediatric Vaccines
- Plant Vaccines & Veterinary Vaccines
- Recombinant Vaccines
- Stem Cell Immunology
- Therapeutic Cancer Vaccines
- Transplant Immunology
- Travel & Edible Vaccinations
- Vaccine Induced Immunity
- Vaccine Types
- Vaccines
- Vaccines and Immunology Advancements
- Vaccines Efficacy and Safety
- Zika Virus Vaccines
Related Journals
Are you interested in
- Animal Models and Biological Research - Vaccines R&D 2021 (Netherlands)
- Bioinformatics and Biotherapeutics - Vaccines R&D 2021 (Netherlands)
- Biomarkers and Case Reports - Vaccines R&D 2021 (Netherlands)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2021 (Spain)
- Cancer, Malaria & TB Vaccines - Vaccines World 2021 (France)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2021 (Spain)
- Clinical Trials, Research and Development - Vaccines R&D 2021 (Netherlands)
- Combination & Conjugate Vaccines - Vaccines World 2021 (France)
- Coronavirus (Covid 19) and Next Generation Vaccines - Vaccines R&D 2021 (Netherlands)
- COVID-19 Vaccine Research & Development - Euro Vaccines 2021 (Spain)
- DNA & Synthetic Vaccines - Vaccines World 2021 (France)
- DNA Vaccines - Euro Vaccines 2021 (Spain)
- Emerging and Infectious Diseases - Vaccines R&D 2021 (Netherlands)
- Hepatitis Vaccines - Euro Vaccines 2021 (Spain)
- HIV Vaccines - Vaccines World 2021 (France)
- HIV Vaccines and Policy Issues - Vaccines R&D 2021 (Netherlands)
- HIV/AIDS Vaccines - Euro Vaccines 2021 (Spain)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2021 (Spain)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2021 (Spain)
- Immunization and Bioprocessing - Vaccines R&D 2021 (Netherlands)
- Immuno-Oncology and Immunotherapy - Vaccines R&D 2021 (Netherlands)
- Immunology/Animal Models - Euro Vaccines 2021 (Spain)
- Influenza and Respiratory Vaccines - Vaccines R&D 2021 (Netherlands)
- Live Attenuated and Inactivated Vaccines - Vaccines R&D 2021 (Netherlands)
- Manufacturing, Production, and Delivery Technologies - Vaccines R&D 2021 (Netherlands)
- Mucosal Vaccines - Euro Vaccines 2021 (Spain)
- New Trends in Vaccines Development - Vaccines World 2021 (France)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2021 (Spain)
- Pediatric Vaccination - Vaccines World 2021 (France)
- Pediatric Vaccines - Vaccines World 2021 (France)
- Public Health and Patient Safety - Vaccines R&D 2021 (Netherlands)
- RDT in Antibiotic Research - Vaccines World 2021 (France)
- Regulatory Licensing and Scientific Affairs - Vaccines R&D 2021 (Netherlands)
- Side-effects of Vaccines - Vaccines World 2021 (France)
- Subunit/Conjugate and Toxoid Vaccines - Vaccines R&D 2021 (Netherlands)
- Toxoid Vaccines - Vaccines World 2021 (France)
- Translational Research on Pandemic Outbreaks - Vaccines R&D 2021 (Netherlands)
- Vaccine Adjuvants - Euro Vaccines 2021 (Spain)
- Vaccine Adjuvants and Antibody Engineering - Vaccines R&D 2021 (Netherlands)
- Vaccine Hesitancy and Health Literacy - Vaccines R&D 2021 (Netherlands)
- Vaccine Production & Development - Vaccines World 2021 (France)
- Vaccine Research & Development - Euro Vaccines 2021 (Spain)
- Vaccine Safety & Efficacy - Vaccines World 2021 (France)
- Vaccine Safety and Efficacy - Vaccines R&D 2021 (Netherlands)
- Vaccines - Vaccines World 2021 (France)
- Vaccines Against Infectious Diseases - Vaccines World 2021 (France)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2021 (Spain)
- Vaccines Business Development - Euro Vaccines 2021 (Spain)
- Vaccines for Older Adults - Euro Vaccines 2021 (Spain)
- Vaccines for Pregnant Women - Vaccines World 2021 (France)
- Vaccines for Respiratory Diseases - Euro Vaccines 2021 (Spain)
- Vaccines for Unconventional Diseases - Vaccines World 2021 (France)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2021 (Spain)
- Vaccines Manufacturing Technologies - Vaccines World 2021 (France)
- Vaccines Research and Clinical Trails - Vaccines World 2021 (France)
- Vaccines safety & Efficacy - Euro Vaccines 2021 (Spain)
- Veterinary Vaccines - Euro Vaccines 2021 (Spain)
- Veterinary Vaccines and Animal Health - Vaccines R&D 2021 (Netherlands)
- Viral Vaccines and Bacterial Vaccines - Vaccines R&D 2021 (Netherlands)
- Virology and Antiviral Drugs - Vaccines R&D 2021 (Netherlands)
- Zika Virus Vaccines - Vaccines World 2021 (France)